IMM 1.49% 34.0¢ immutep limited

Ann: Immutep granted European patent for eftilagimod alpha, page-3

  1. 25,397 Posts.
    lightbulb Created with Sketch. 1377
    Immutep in pursuing this self protective agenda is a hint of research
    confidence coming from our chief scientist and his research labs.....
    Immutep is basically securing it's future if Frederic and his team
    can get "Efti" over the line.....The fundamentals of a sound business
    base are there but let's not get carried away yet, the business is
    not ready to produce and production is not assured......
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.